MML Investors Services’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-9,487
Closed -$313K – 2790
2024
Q4
$313K Buy
+9,487
New +$358K ﹤0.01% 2233
2021
Q4
– Sell
-14,141
Closed -$644K – 2061
2021
Q3
$644K Buy
14,141
+465
+3% +$21.3K 0.01% 1229
2021
Q2
$669K Buy
13,676
+1,878
+16% +$90K 0.01% 1182
2021
Q1
$593K Buy
11,798
+5,295
+81% +$293K 0.01% 1181
2020
Q4
$333K Sell
6,503
-357
-5% -$17K ﹤0.01% 1341
2020
Q3
$282K Buy
+6,860
New +$283K ﹤0.01% 1323
2020
Q2
– Sell
-10,479
Closed -$332K – 1556
2020
Q1
$332K Sell
10,479
-1,996
-16% -$76.3K 0.01% 1051
2019
Q4
$527K Sell
12,475
-524
-4% -$19.4K 0.01% 985
2019
Q3
$410K Sell
12,999
-1,499
-10% -$52.7K 0.01% 1027
2019
Q2
$524K Sell
14,498
-956
-6% -$33K 0.01% 998
2019
Q1
$559K Buy
15,454
+1,171
+8% +$39.1K 0.01% 961
2018
Q4
$402K Sell
14,283
-2,610
-15% -$86.5K 0.01% 1014
2018
Q3
$665K Buy
16,893
+1,007
+6% +$38.2K 0.01% 853
2018
Q2
$592K Buy
15,886
+1,997
+14% +$72.4K 0.01% 772
2018
Q1
$475K Buy
+13,889
New +$487K 0.01% 863

Other funds holding SBIO

MML Investors Services's SBIO Position: Q1 2025 in Review

MML Investors Services sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2025, closing a stake of 9,487 shares — an estimated $313K sold.

MML Investors Services first reported a position in SBIO in Q1 2018 and held it in 15 quarters. The position peaked at $669K in Q2 2021. 35 funds tracked by Wall St. Rank hold SBIO as of Q1 2025.

  • MML Investors Services reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2025 after selling out during the quarter.
  • MML Investors Services sold 9,487 ALPS Medical Breakthroughs ETF shares in Q1 2025, an estimated $313K.
  • MML Investors Services first reported a position in ALPS Medical Breakthroughs ETF in Q1 2018 and held it in 15 quarters.
  • MML Investors Services's ALPS Medical Breakthroughs ETF position peaked at $669K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2025.

Based on MML Investors Services's 13F filing for Q1 2025, filed 14 May 2025.